Insulin glulisine mimics the pharmacokinetic and pharmacodynamic profiles of physiological human insulin, has a rapid onset, peak effect at 1 h, and a shorter duration of action (~4 h).

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed ...